Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
national blog main
boston blog main
boston top stories
clinical trials
national top stories
acute myeloid leukemia
boston
deals
fda
investing
san francisco blog main
startups
480 biomedical
adverum biotechnologies
ally bridge group
alx oncology
ambit biosciences
arsenal medical
athena countouriotis
autoimmune diseases
berkeley lights
big data analytics
biotech ipos
blackrock
bob langer
brett zbar
bristol-myers squibb
cancer drugs
cancer immunotherapy
casdin capital
cd47
chronic kidney disease
chronic rhinosinusitis
cormorant asset management
covid-19
daiichi sankyo
deerfield healthcare technology acquisitions
deerfield management company
What
biotech
4
×
new
4
×
raised
4
×
ipo
million
company
drug
raises
therapeutics
analysis
arrival
athena
bio
bring
cancer
ceo
chief
companies
countouriotis
days
debut
develop
developing
diseases
employing
financing
genetic
gets
goldfinch
hasn’t
industry
ipos
kidney
late
later
lead
life
lyra
market
markets
Language
unset
Current search:
biotech
×
raised
×
new
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push